Scleroderma and solvent exposure among women

American Journal of Epidemiology

Volumn 157, Issue 6, 2003, Pages 493-500

  Garabrant, David H ^a,b   Lacey Jr , James V ^a,c   Laing, Timothy J ^b   Gillespie, Brenda W ^d   Mayes, Maureen D ^e   Cooper, Brenda C ^a   Schottenfeld, David ^a,b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Occupational exposure; Scleroderma; Solvents; Systemic; Tetrachloroethylene; Trichloroethanes; Trichloroethylene

Indexed keywords

CHLORINATED HYDROCARBON; GASOLINE; PETROLEUM DERIVATIVE; SOLVENT; TETRACHLOROETHYLENE; THINNER; TRICHLOROETHANE; TRICHLOROETHYLENE;

HEALTH RISK; MEDICAL GEOGRAPHY; OCCUPATIONAL EXPOSURE; RISK FACTOR; SKIN DISORDER; SOLVENT; WOMENS HEALTH;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OCCUPATIONAL EXPOSURE; POPULATION RESEARCH; RISK ASSESSMENT; SCLERODERMA; SELF REPORT; TELEPHONE; UNITED STATES;

CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HOBBIES; HUMANS; MICHIGAN; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OHIO; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SOLVENTS;

UNITED STATES;

EID: 0037443591     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf223     Document Type: Article

References (46)

1. Garabrant DH, Dumas C. Epidemiology of organic solvents and connective tissue disease. Arthritis Res 1999;2:5-15.
2. Laing TJ, Gillespie BW, Toth MB, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997;40:734-42.
3. Czirjak L, Bokk A, Csontos G, et al. Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol 1989;69:533-6.
4. Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998;41:1111-18.
5. Goldman JA. Connective tissue disease in people exposed to organic chemical solvents. Systemic sclerosis (scleroderma) in dry cleaning and aircraft industry workers. J Clin Rheumatol 1996;2:185-90.
6. Bovenzi M, Barbone F, Betta A, et al. Scleroderma and occupational exposure. Scand J Work Environ Health 1995;21:289-92.
7. Walder BK. Do solvents cause scleroderma? Int J Dermatol 1983;22:157-8.
8. Silman AJ, Hochberg MC. Occupational and environmental influences on scleroderma. Rheum Dis Clin North Am 1996;22:737-49.
9. Bottomley WW, Sheehan-Dare RA, Hughes P, et al. A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol 1993;128:203-6.
10. Brasington RC, Thorpe-Swenson AJ. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arthritis Rheum 1991;34:631-3.
11. Yanez-Diaz S, Moran M, Unamuno P, et al. Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatology 1992;184:98-102.
12. Toxicological profile for vinyl chloride. Washington, DC: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, 1997:1-277.
13. Black CM, Walker AE, Catoggio LJ, et al. Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet 1983;1:53-5.
14. Haustein UF, Ziegler V. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 1985;24:147-51.
15. Burns CJ, Laing TJ, Gillespie BW, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 1996;23:1904-11.
16. Lacey JV Jr, Garabrant DH, Laing TJ, et al. Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol 1999;149:761-70.
17. Laing TJ, Schottenfeld D, Lacey JV Jr, et al. Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devices. Am J Epidemiol 2001;154:610-17.
18. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
19. Lepkowski JM. Telephone sampling methods in the United States. In: Groves R, ed. Telephone survey methodology. New York, NY: John Wiley & Sons, Inc, 1988:73-98.
20. Fritschi L, Siemiatycki J, Richardson L. Self-assessed versus expert-reviewed occupational exposures. Am J Epidemiol 1996;144:521-7.
21. Siemiatycki J, Fritschi L, Gerin M. Reliability of an expert rating procedure for retrospective assessment of occupational exposures in community based case-control studies. Am J Ind Med 1997;31:280-6.
22. Prentice RL, Breslow NE. Retrospective studies and future time models. Biometrika 1978;65:153-8.
23. Breslow NE, Day NE. Statistical methods in cancer research. Vol I. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980:1-338. (IARC scientific publication no. 32).
24. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50:1064-72.
25. SAS Institute, Inc. SAS/STAT software: changes and enhancements through release 6.12. Cary, NC: SAS Institute, Inc, 1997:1-1167.
26. Lockey JE, Kelly CR, Cannon GW, et al. Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med 1987;29:493-6.
27. Flindt-Hansen H, Isager H. Scleroderma after occupational exposure to trichloroethylene and trichloroethane. Acta Derm Venereol 1987;67:263-4.
28. Reveille J, Durban E, MacCleod-St. Clair M, et al. Association of amino acid sequences in the HLA-DBQ1 first domain with the anti-topoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992;90:973-80.
29. Beirne GJ. Goodpasture's syndrome and exposure to solvents. JAMA 1972;222:1555.
30. Kleinknecht D, Morel-Maroger L, Callard P, et al. Antiglomerular basement membrane nephritis after solvent exposure. Arch Intern Med 1980;140:230-2.
31. Brogren CH, Christensen JM, Rasmussen K. Occupational exposure to chlorinated organic solvents and its effect on the renal excretion of N-acetyl-beta-D-glucosaminidase. Arch Toxicol Suppl 1986;9:460-4.
32. Cavender F. Aromatic hydrocarbons. In: Clayton GD, Clayton FE, eds. Patty's industrial hygiene and toxicology. New York, NY: John Wiley & Sons, Inc, 1994:1301-442.
33. Gleason MN, Gosselin RE, Hodge HC. Clinical toxicology of commercial products. Baltimore, MD: Williams & Wilkins Co, 1957:237-1068.
34. Gleason MN, Gosselin RE, Hodge HC. Clinical toxicology of commercial products. Baltimore, MD: Williams & Wilkins Co, 1963:1-675.
35. Gleason MN, Gosselin RE, Hodge HC, et al. Clinical toxicology of commercial products. Baltimore, MD: Williams & Wilkins Co, 1969:1-772.
36. Gosselin RE, Hodge HC, Smith RP, et al. Clinical toxicology of commercial products. Baltimore, MD: Williams & Wilkins Co, 1976:1-799.
37. Gosselin RE, Smith RP, Hodge HC. Clinical toxicology of commercial products. Baltimore, MD: Williams & Wilkins Co, 1984:1-735.
38. Silman AJ, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992;51:1322-4.
39. Sparrow GP. A connective tissue disorder similar to vinyl chloride disease in a patient exposed to perchloroethylene. Clin Exp Dermatol 1977;2:17-22.
40. Saihan EM, Burton JL, Heaton KW. A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon, and peripheral neuropathy. Br J Dermatol 1978;99:437-40.
41. Hansen BL, Isager H. Skerodermilignende sygdom - eksposition for frikloraetan og trikloraetylen, en kausal sammenhaeng? [A scleroderma-resembling disease - exposure to trichloroethylene and trichloroethane, is there a causal connection?] (In Danish). Ugeskr Laeger 1988;150:805.
42. Czirjak L, Csiki Z, Nagy Z, et al. Exposure to chemicals and systemic sclerosis. Ann Rheum Dis 1995;54:529.
43. Garcia-Zamalloa AM, Ojeda E, Gonzalez-Beneitez C, et al. Systemic sclerosis and organic solvents: early diagnosis in industry. Ann Rheum Dis 1994;53:618.
44. Haustein UF, Ziegler V. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 1985;24:147-51.
45. Czirjak L, Schlammadinger J, Szegedi G. Systemic sclerosis and exposure to trichloroethylene. (Letter). Dermatology 1993;186:236-7.
46. Dry cleaning, some chlorinated solvents, and other industrial chemicals. Vol 63. Lyon, France: International Agency for Research on Cancer, 1995:33-71.